PreveCeutical Responds to British Columbia Securities Commission Press Release Cannabis Investing News
Precipio ICE COLD-PCR Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study Life Science Investing
Naturally Splendid Secures National Distribution for Pawsitive FX™ Pet Product Line Cannabis Investing News
Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study Pharmaceutical Investing
SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Clinical Study of Nelipepimut-S Pharmaceutical Investing
